半岛bd体育手机客户端 说明
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.
生化/生理作用
Capecitabine is an anti-cancer drug, a prodrug of doxifluridine, metabolized to 5-fluorouracil at the tumor site. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5′-Deoxy-5-fluorocytidine (5′-DFCR) and 5′-Deoxy-5-fluorouridine (5′-DFUR), to form 5-fluorouracil.
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
基本信息
经验(实验)分子式 | C15H22FN3O6 |
分子量 | 359.35 |
MDL编号 | MFCD00930626 |
PubChem化学物质编号 | 329749220 |
NACRES | NA.24 |
半岛bd体育手机客户端 性质
等级 | pharmaceutical primary standard |
manufacturer/tradename | USP |
application(s) | pharmaceutical (small molecule) |
格式 | neat |
SMILES string | O[C@H]1[C@@H](O)[C@H](N2C(N=C(NC(OCCCCC)=O)C(F)=C2)=O)O[C@@H]1C |
InChI | 1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1 |
InChI key | GAGWJHPBXLXJQN-UORFTKCHSA-N |
Gene Information | human ... TYMS(7298) |
安全信息
象形图 | |
警示用语: | Danger |
危险声明 | H341 - H350 - H360FD |
预防措施声明 | P201 - P280 - P308 + P313 |
危险分类 | Carc. 1B - Muta. 2 - Repr. 1B |
储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
Sigma-Aldrich